INTRODUCTION
The life cycle of human immunodeficiency virus type 1 (HIV-1), as with other retroviruses, involves reverse transcription, i.e. conversion of the single-stranded RNA of the virus genome into the double-stranded DNA of the provirus. According to the genera] model of reverse transcription, summarized by Gilboa et al. [10] , all reactions of this complex process are catalyzed by a multifunctional virus-encoded enzyme, reverse transcriptase (RT). Three distinct enzymatic activities have been associated with retroviral RT (reviewed in [11] ): (i) RNA-dependent DNA polymerase activity is involved in synthesis of the minus-strand DNA, using tRNA primer hybridized to the plus-strand RNA template; (ii) RT-associated RNase H degrades the RNA chain in the RNA. DNA intermediate and generates an RNA primer for synthesis of the plus-strand DNA, which is catalyzed by (iii) the DNA-dependent DNA polymerase activity of RT. RNase H is also believed to be involved in the final removal of the RNA primers.
Recently, an additional activity was reported to be associated with recombinant RT of HIV-1 [2] . This unexpected activity specifically cleaves RNA in a double-stranded RNA region, which is formed in the initiation complex by human tRNA Lys ' 3 primer hybridized to the complementary sequence of 18 nucleotides in the viral RNA, the minus-strand primer binding site (PBS). A specific cleavage by this activity, referred to as RNase D, was reported to occur at two distinct sites within the PBS sequence in the in vitro reaction. Since RT is an essential enzyme of retroviral replication, it represents a prime target for antiviral therapy [22] . The reported discovery of a new activity associated with this enzyme has already led to initiation of extensive drug screening programs [29] . It is believed that compounds specifically inhibiting the potentially important RNase D function of RT could lead to development of drugs against HIV infection and AIDS.
To study in more detail the RNase D activity of HIV-1 RT, we prepared an RNA substrate, which resembles the primertemplate complex, composed of human tRNA Lys hybridized to the PBS region of HIV-1 genome. Using this substrate, we could confirm the presence of RNase D activity in our preparations of various mutated forms of recombinant HIV-1 RT. Furthermore, we also found that this activity displays the same cleavage specificity as purified RNase HI, a double-strand specific processing endoribonuclease involved in maturation of RNA precursors in E.coli [5, 27, 8] .
MATERIALS AND METHODS
Bacterial strains E.coli strain AP401 (/o«:mini tet R , am-, lac Pro, nallA, argE am, rifR, thi-1, [F, pro AB, ladiZ M15]) [13] has been commonly used for preparation of recombinant proteins in our laboratory. E.coli strain BL214 (Hfr, PO45, thi-1, ura?U9, rnc-105, rel-1) [28] was used as an RNase III-host for preparation of HIV-1 RT.
Enzymes
Various forms of recombinant HTV-1 RT tested in this study were prepared as described [14, 15] . Briefly, RTs were purified from soluble E.coli lysates using three chromatographic steps: separation on Heparin Sepharose CL-6B followed by FPLC Mono Q and hydroxy apatite Bio-Gel HT chromatography. Purity of the final preparations was quantified by laser densitometry of Coomassie-blue-stained SDS/16% polyacrylamide gels. RT samples of 40 /ig were found to be at least 98% pure.
E.coli RNase in, purified according to Chen et al. [4] , was a gift of A.Nicholson. All incubations with RNA substrates were performed in a buffer containing 50 mM Tris-HCl, pH 8.0, 50 mM KC1, 7 mM MgCl 2 and 5 mM dithiothreitol, unless indicated otherwise.
Preparation of RNA substrates
The sequence encoding the tRNA-PBS substrate was assembled from synthetic oligodeoxyribonucleotides and inserted between EcoR I and Sal I sites of plasmid pTZ18R (Pharmacia LKB), downstream from the T7 promoter. The resulting plasmid pTRS31, linearized by Nsi I or 5a/1 was used as a template for run-off RNA synthesis using a T7 transcription kit (Ambion). The RNA product was incubated with calf intestine alkaline phosphatase (NEN), 5'-end labeled by [ 7 - 32 P]rATP and polynucleotide kinase (Boehringer). The unincorporated radioactivity was removed by passing through a sizing column (NucTrap-Stratagene). The main fraction of the RNA substrate was precipitated by ethanol and used in enzymatic reactions without further purification.
Bacteriophage T7 Rl.l RNase m processing signal was prepared from a synthetic oligodeoxyribonucleotide template (gift of A.Nicholson) by in vitro transcription as described [3] , using [7- 32 P]rGTP incorporation for 5'-end labeling.
RESULTS

Enzymatic synthesis of the tRNA-PBS substrate
Reverse transcription of the HIV-1 genome is primed from the 3' OH end of the cellular tRNA 1 -* 0 , annealed to an 18-base viral RNA sequence, called the primer binding site (PBS). We have prepared an RNA substrate composed of the full sequence of human tRNA L * s -3 extended by a sequence corresponding to the PBS sequence of HIV-1, so that a double-stranded RNA region can be formed as a result of intramolecular hybridization ( Fig. 1 ). As this substrate is made of a single RNA chain, the tRNA and the PBS segments in the RNA preparation are, by definition, present in an equimolar ratio. We did not observe any significant difference in double-strand specific RNA cleavage between preparations of the tRNA-PBS substrate, which were allowed to self-anneal by heating to 80°C followed by slow cooling to room temperature, and the preparations that were not incubated at elevated temperature. This observation suggests that the relevant double-stranded structure in the substrate forms efficiently at 37°C, presumably in the course of RNA synthesis. As this RNA was prepared by in vitro transcription using T7 polymerase, the tRNA moiety of the tRNA-PBS substrate is unmodified. It should be noted, however, that the synthetic unmodified tRNA 1 * 0 was reported not to differ from the authentic tRNA L y s ' 3 species in its ability to bind HIV-1 RT and to initiate minus-strand DNA synthesis [1] . A synthetic tRNA primer-template complex was also used as a substrate to demonstrate the RNase D activity of HIV-1 RT [2] . Double-stranded RNA-dependent cleavage of the tRNA-PBS substrate by recombinant HIV-1 RT and E.coli RNase III Incubation of the 5'-end-labeled tRNA-PBS substrate with preparations of recombinant HTV-1 RT resulted in the appearance of two major products on a sequencing gel. The pattern corresponds to prominent cleavage at two sites separated by four nucleotides in the PBS sequence of the double-stranded region, in agreement with the reported cleavage by RNase D activity associated with HIV-1 RT [2] . A minor cleavage site was also observed, just one nucleotide downstream from the 5'-terminal major cleavage site. Incubation of the substrate with the isolated RNase in produced the same pattern of cleavage products as with RT (Fig. 2, lanes 2,3 and 5, 6, 7) . The observed bands seem to represent the final products of the processing as the pattern did not change with increasing concentration of the enzymes. To locate the RNase D and RNase m cleavage sites in the PBS region of the tRNA-PBS substrate, the reaction products were electrophoresed in a sequencing gel along with RNA fragments of known size and nucleotide sequence (Fig. 2, lanes 13,14) . The fragments contain free 3' OH and are 32 P-labeled in their 5'-terminal phosphate group. The deduced positions of cleavage (cf. Fig. 1 ) are in agreement with the conclusion of a study on cleavage specificity of RNase m [20] , which suggests that RNase HI cleavage occurs at one or more preferred sites located 10 to 14 nucleotides from the 3'-terminus of the complementary region.
The characteristic cleavage pattern remained unchanged when the tRNA-PBS substrate was extended by 10 unpaired nucleotides at its 3'-terminus. This form of tRNA-PBS substrate was prepared by using the plasmid pTRS31 linearized by Sal /, rather than Nsi I, as a template for run-off transcription by T7 RNA polymerase (cf. Fig. 1 ). The identical cleavage pattern indicates that the authentic 3'-terminus of tRNA is not required for the specific cleavage in the double stranded portion of the RNA substrate, by either RNase D or RNase m (Fig.2, lanes 22 and  23) .
Several mutated forms of HTV-1 RT prepared in our laboratory also displayed RNase D activity, as judged from the same pattern of degradation products as with the wild type enzyme.These are: RT-NN15-RT heterodimer with mutations Asp443-Asn and Asp498-Asn (Fig.2, lane 9) ; NRTEQ1-monomeric p51 subunit of HIV-1 RT, with mutation AspllO-Gln (Fig.2, lane 10) and eRH2-76-chimaeric heterodimer of RT composed of HIV-1 polymerase domain and HTV-2 RNase H domain (Fig.2, lane 12) .
The characteristic cleavage in the double-stranded region was not observed, however, when the tRNA-PBS substrate was incubated with the isolated RNase H domain of HIV-1 RT (Fig. 2, lane 11) or other enzymes unrelated to HIV-1 RT, such as E.coli RNase H (Fig. 2, lane 19) , pancreatic RNase A (Fig. 2,  lanes 17, 18) or glycinamide ribonucleotide (GAR) transformylase (Fig. 2, lane 21) . Furthermore, no cleavage by RNase D activity of RT or by RNase HI was observed when the tRNA-PBS substrate was incubated in the absence of Mg 2+ (Fig. 2, lanes 15, 16) , indicating requirement of these doublestranded RNA-dependent activities for divalent metal cations.
Cleavage of bacteriophage T7 Rl.l RNase III processing signal by preparations of recombinant RT Of the natural RNase III processing substrates studied so far, all prominently feature RNA-RNA duplex secondary structure. To compare the RNase D and RNase III activities on a well characterized prokaryotic substrate of RNase HI, we prepared RNA containing the bacteriophage T7 Rl. 1 RNase HI processing signal. The Rl.l RNA was shown to be accurately processed in vitro by RNase HI [24] . The cleavage occurs in the sequence UUAU*GAUUG within the internal loop, which is also the in vivo cleavage site [3] . As is apparent from Fig.3 , lanes 1-6, both isolated RNase m and different forms of recombinant HTV-1 RT can cleave the Rl.l RNA . The identical electrophoretic mobility of the cleavage products indicate that all preparations cleave the Rl.l substrate at the same site.
Comparison of RNase D and RNase III activities
To summarize the data from Fig.2 and 3 , the RNase D activity of HFV-1 RT and E.coli RNase m appear to be remarkably similar with regard to the following characteristics: -Both activities display identical cleavage specificity on two different substrates containing double-stranded RNA regions, -Both activities require Mg 2+ for specific cleavage, -Both activities have a similar activity profile in high salt (Fig.3, lanes 8-11) . The only major difference between RNase D and RNase HI was in their apparent specific activity. As can be seen from the dilution series (Fig. 2, lanes 2-8) , at least 100 times more RT than RNase III was required to obtain a comparable level of substrate cleavage. 
Absence of cleavage of tRNA-PBS substrate by HIV-1 RT purified from an RNase III-strain of E.coli
To explore the possibility that RNase D activity of HTV-1 RT is caused by contamination of the recombinant protein by RNase DI of the bacterial host, we also expressed RT in a strain of E.coli that is deficient in RNase HI activity due to the presence in its genome of the mutation rnc-105 [28] . Since this strain (BL214) is an Hfr strain, the same type of induction and purification protocols were used as for the preparation of recombinant RT from the strain AP401, which carries the wild type gene for RNase IE. As seen in Fig.4 , RT purified from the RNase IE" strain of E.coli did not cleave the tRNA-PBS substrate.
DISCUSSION
To study events associated with initiation of reverse transcription by RT, we have prepared an RNA substrate, which has salient features of the presumed primer-template initiation complex in reverse transcription of the HIV-1 genome. In particular, the substrate contains the full sequence of tRNA Lys>3 and a segment of HTV-1 RNA with minus-strand primer binding site (PBS). The two segments are connected with a short linker sequence in such a way that the 3'-terminal portion of tRNA Lys -3 can form a 18 bp double-stranded region with the complementary sequence of PBS (cf. Fig. 1 ). When this substrate was incubated with our preparation of HIV-1 RT, we could detect a specific cleavage at two positions of the double-stranded region. This observaton is in agreement with the recent report by Ben-Artzi et al. [2] , describing a new activity associated with HIV-1 RT, called RNase D, which cleaves with a similar specificity. (It should be noted that the choice of RNase D as the name for this activity is potentially confusing since there already is a well characterized E.coli enzyme with the same designation [6] ).The positions of cleavage sites in the double-stranded RNA substrate deduced in our experiment were one nucleotide away from the published sequence, although the distance between the cleavage sites was the same as reported (4 nucleotides). The source of this minor discrepancy may be in a low resolution of the sequencing gel presented in Fig.5 of the original report [2] .
In an attempt to map the new activity of RT on the RT polypeptide, we examined several mutated forms of HIV-1 RT prepared in our laboratory and found that most of them also exhibited the RNase D activity.
The mutant RT-NN15, originally described by Mizrahi et al. [23] , has two mutations in the RNase H domain, Asp443-Asn and Asp498-Asn. This form of RT displays unimpaired DNA polymerase activity on both RNA and DNA templates, but is completely devoid of RNase H function [23, 15] , The absence of RNase H activity is explained by amidation of carboxyl groups of the two active site residues, which are involved in coordinating divalent metal cations, as is apparent from our previous studies of the crystal structure of this domain [7] . The presence in this mutant of RNase D activity thus excludes catalytic involvement of the RNase H active site in the RNase D cleavage. The latter conclusion is further supported by the observation that the isolated p51 subunit of HIV-1 RT, which is lacking the RNase H domain, still displays RNase D activity. The p51 protein corresponds to the DNA polymerase domain of HIV-1 RT and contains polymerase catalytic site and substrate binding site. Interestingly, the form of p51 with mutation AspllO-Gln, also displayed RNase D activity. This mutation, originally described by Larder et al. [21] , completely abolishes the polymerase activity of HIV-1 RT. Based on the alignment of the primary structures of known polymerases, Aspl 10 corresponds to the only invariant residue in the conserved motif A [26] . The biological relevance of this alignment has been reinforced by comparison of the crystal structure of the Klenow fragment of E. coli DNA polymerase I [25] and that of HIV-1 RT [19] . The region with Aspl 10 in RT folds in an analogous way as the corresponing region containing Asp7O5 in the Klenow fragment, which directly implicates Aspl 10 as an active site residue of RT [19] . The fact that the Aspl 10-Gln mutant still exhibits RNase D activity would thus lead one to postulate a different, third, active site for RNase D on the RT polypeptide, which site would be independent of the polymerase function (For a recent review on structure-function relationship in HIV-1 RT see [17] ).
Our results, showing that the recently reported RNase D activity of HIV-1 RT and RNase in of E.coli cleave specific substrates in an identical fashion, offer two alternative explanations. The observed RNase D activity is either (i) an integral part of HIV-1 RT displaying the same cleavage specificity as RNase HI of E.coli, or (ii) it represents a low level contamination with RNase HI, as the recombinant forms of RT have been purified from E.coli extracts.
In the former case, the inherent RT activity would have the following characteristics: It should reside on the p51 domain of HTV-1 RT, and have an autonomous active site, as this activity is independent of both RNase H and DNA polymerase functionalities of HTV-1 RT. The definitive genetic support for this possibility would require identification of specific active site mutations, presumably involving carboxylic residues, implied by the requirement of RNase D acivity for divalent metal cations.
Alternatively, the observed specific cleavage of the doublestranded RNA substrates may be attributed to trace amounts of E.coli RNase III in the preparations of recombinant RT. To explore this possibility, we have included in our assays several unrelated recombinant proteins overexpressed in the same E. coli host strain as HIV-1 RT, such as E.coli RNase H, a fusion protein of dihydrofolate reductase-RNase H domain of Moloney murine leukemia virus and human glycinamide ribonucleotide (GAR) transformylase (Fig. 2, lanes 19, 20 and 21, respectively) . None of these proteins, however, displayed contamination by RNase HI, as judged by the absence of the characteristic cleavage pattern. So far, the presumed contamination by RNase HI seems to be specific for preparations of RT. This could be explained by a similar chromatographic behavior of these two proteins. As BenArtzi et al. [2] did not detect any cleavage in bacterial mock protein fraction purified by the same procedure as RT, the possibility of a specific affinity between RT and RNase El cannot be excluded.
In contrast to RNase III, relatively high amounts of RT protein were required to detect the specific cleavage of the tRNA-PBS substrate. Based on the known concentration of the purified proteins, we attempted to estimate the amount of E.coli RNase HI in RT preparations that would be required to detect its activity. From the dilution series with RNase III and RT preparations (Fig. 2, lines 2-8) , the minimum amounts of the respective enzymes displaying a comparable cleavage differ by at least two orders of magnitude. The RNase D activity of RT preparations could thus be explained by presence of less than 1% contamination due to RNase in, which would escape detection by a standard Coomassie blue staining of the polyacrylamide gels.
In contrast to the different RT forms prepared from the RNase III + strain of E.coli, even high amounts of the wild type RT purified from an RNase HI" strain of E.coli failed to cleave the tRNA-PBS substrate.
Taken together, our experiments provide a strong support for the explanation that the reported RNase D activity of HIV-1 RT is caused by the RNase HI contamination rather than being an inherent RT activity with the same cleavage specificity as RNase III. Alternative experiments could be proposed that would be equally conclusive with regard to the question of the RNase HI contamination.These could include e.g.: demonstrating depletion of the RNase D activity of HTV-1 RT by specific antibodies against E.coli RNase IE; applying a dramatically different purification scheme (we have a preliminary evidence that forms of RT with hexahistidine label purified by metal chelate affinity chromatography as described [12] do not display RNase HI cleavage); testing RT prepared directly from HIV-1 virions (the AMV RT which did not cleave the substrate used in the assay of Ben-Artzi et al. [2] was purified from Avian myeloblastosis virus); or testing recombinant HFV-1 RT isolated from host organisms other than E.coli.
Our results, besides providing additional information concerning the target sequences recognized by E.coli RNase HI, substantiate caution in interpreting activities detected in preparations of recombinant enzymes.
